53 related articles for article (PubMed ID: 16982177)
1. Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant.
Sheng JJ; Kasim NA; Chandrasekharan R; Amidon GL
Eur J Pharm Sci; 2006 Nov; 29(3-4):306-14. PubMed ID: 16982177
[TBL] [Abstract][Full Text] [Related]
2. Efficiency of single pharmaceutical surfactants to mimic intestinal biorelevant media solubilization and dissolution of etravirine: Comparison of intrinsic and film dissolution models.
Oktay AN; Polli JE
Eur J Pharm Sci; 2024 May; 196():106746. PubMed ID: 38499112
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Discriminative Dissolution Medium for a Poorly Soluble Nutraceutical Tetrahydrocurcumin.
Shiek Abdul Kadhar Mohamed Ebrahim HR; Chungath TT; Sridhar K; Siram K; Elumalai M; Ranganathan H; Muthusamy S
Turk J Pharm Sci; 2021 Oct; 18(5):565-573. PubMed ID: 34719154
[TBL] [Abstract][Full Text] [Related]
4. Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base Drugs.
Matsumura N; Ono A; Akiyama Y; Fujita T; Sugano K
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32899235
[TBL] [Abstract][Full Text] [Related]
5. Medicinal products with pH-dependent solubility-A problem for BA/BE assessment?
Blume H; Weitschies W
Eur J Pharm Sci; 2024 May; 196():106756. PubMed ID: 38556065
[TBL] [Abstract][Full Text] [Related]
6. Cosolvent solubilization and formulation of an aqueous injection of ketoprofen.
Singhai AK; Jain S; Jain NK
Pharmazie; 1996 Oct; 51(10):737-40. PubMed ID: 8941941
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an aqueous injection of ketoprofen.
Singhai AK; Jain S; Jain NK
Pharmazie; 1997 Feb; 52(2):149-51. PubMed ID: 9122274
[TBL] [Abstract][Full Text] [Related]
8. Central analgesic effect of ketoprofen in humans: electrophysiological evidence for a supraspinal mechanism in a double-blind and cross-over study.
Wilier JC; De Broucker T; Bussel B; Roby-Brami A; Harrewyn JM
Pain; 1989 Jul; 38(1):1-7. PubMed ID: 2780057
[TBL] [Abstract][Full Text] [Related]
9. Solubility vs Dissolution in Physiological Bicarbonate Buffer.
Claussen F; Al-Gousous J; Salehi N; Garcia MA; Amidon GL; Langguth P
Pharm Res; 2024 May; 41(5):937-945. PubMed ID: 38698196
[TBL] [Abstract][Full Text] [Related]
10. Thermodynamic Correlation between Liquid-Liquid Phase Separation and Crystalline Solubility of Drug-Like Molecules.
Uekusa T; Watanabe T; Watanabe D; Sugano K
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559054
[TBL] [Abstract][Full Text] [Related]
11. Drug Physicochemical Properties and Capsule Fill Determine Extent of Premature Gastric Release from Enteric Capsules.
Moghrabi FS; Fadda HM
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432696
[TBL] [Abstract][Full Text] [Related]
12. In vitro pH dependent passive transport of ketoprofen and metformin.
Elezović A; Marić A; Biščević A; Hadžiabdić J; Škrbo S; Špirtović-Halilović S; Rahić O; Vranić E; Elezović A
ADMET DMPK; 2021; 9(1):57-68. PubMed ID: 35299877
[TBL] [Abstract][Full Text] [Related]
13. Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms.
Lex TR; Rodriguez JD; Zhang L; Jiang W; Gao Z
AAPS J; 2022 Mar; 24(2):40. PubMed ID: 35277760
[TBL] [Abstract][Full Text] [Related]
14. A homogenous nanoporous pulmonary drug delivery system based on metal-organic frameworks with fine aerosolization performance and good compatibility.
Zhou Y; Niu B; Wu B; Luo S; Fu J; Zhao Y; Quan G; Pan X; Wu C
Acta Pharm Sin B; 2020 Dec; 10(12):2404-2416. PubMed ID: 33354510
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of
Hou X; Zhang W; He M; Lu Y; Lou K; Gao F
Asian J Pharm Sci; 2017 Nov; 12(6):558-568. PubMed ID: 32104369
[No Abstract] [Full Text] [Related]
16. Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties.
Mudie DM; Samiei N; Marshall DJ; Amidon GE; Bergström CAS
AAPS J; 2020 Jan; 22(2):34. PubMed ID: 31989343
[TBL] [Abstract][Full Text] [Related]
17. Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions.
Bermejo M; Paixão P; Hens B; Tsume Y; Koenigsknecht MJ; Baker JR; Hasler WL; Lionberger R; Fan J; Dickens J; Shedden K; Wen B; Wysocki J; Löbenberg R; Lee A; Frances A; Amidon GE; Yu A; Salehi N; Talattof A; Benninghoff G; Sun D; Kuminek G; Cavanagh KL; Rodríguez-Hornedo N; Amidon GL
Mol Pharm; 2018 Dec; 15(12):5454-5467. PubMed ID: 30372084
[TBL] [Abstract][Full Text] [Related]
18. Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System.
Bou-Chacra N; Melo KJC; Morales IAC; Stippler ES; Kesisoglou F; Yazdanian M; Löbenberg R
AAPS J; 2017 Jul; 19(4):989-1001. PubMed ID: 28516359
[TBL] [Abstract][Full Text] [Related]
19. pH-Dependent Solubility and Dissolution Behavior of Carvedilol--Case Example of a Weakly Basic BCS Class II Drug.
Hamed R; Awadallah A; Sunoqrot S; Tarawneh O; Nazzal S; AlBaraghthi T; Al Sayyad J; Abbas A
AAPS PharmSciTech; 2016 Apr; 17(2):418-26. PubMed ID: 26202065
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
